Brought to you by 
Neuro3d completes €20mm second round
09 Oct 2002
Executive Summary
Neuro3d (French company developing drugs to prevent and treat CNS disorders) has completed a €20mm ($19.4mm) Series B private financing led by HealthCap and Techno Venture Management. Returning investors Soffinova Partners and Apax Partners also participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neuro3d completes €20mm second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice